Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yang Ou's publication output changed over time?
ScholarIQpublication output · 2008–2025
Output grew100% over the shown period — from 1 works in 2008 to 2 in 2025.
1
1
1
1
1
3
2
2008201120182019202020242025
What are the most-cited papers on Yang Ou?
ScholarIQmost cited works
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
Christopher M. Kramer, Barry A. Borlaug, Michael R. Zile, Dustin Ruff, Joseph M DiMaria, Venu Menon, Yang Ou, Angela M Zarante, Karla Hurt, Masahiro Murakami, Milton Packer
Journal of the American College of Cardiology. 2024159 CitationsOPEN ACCESS
Salivary diagnostics: opportunities and challenges
Yuxin Li, Yang Ou, Kexin Fan, Guozhen Liu
S2482500137. 202467 CitationsOPEN ACCESS
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
Michael R. Zile, Barry A. Borlaug, Christopher M. Kramer, Seth J. Baum, Sheldon E. Litwin, Venu Menon, Yang Ou, Govinda J. Weerakkody, Karla Hurt, Chisom Kanu, Masahiro Murakami, Milton Packer, for the SUMMIT Trial Study Group
Circulation. 202464 CitationsOPEN ACCESS
Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU+P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC).
Yang Ou, M. Dror Michaelson, L. Sengeløv, Farid Saad, Nadine Houédé, Peter Ostler, A. Stenzl, Gedske Daugaard, Robert J. Jones, F. Laestadius, Amit Bahl, Daniel Castellano, J. Gschwend, Tristan Maurina, D. Ye, I. Chen, S. Wang, Edna Chow Maneval, Stéphane Oudard
Journal of Clinical Oncology. 201156 Citations
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
Milton Packer, Michael R. Zile, Christopher M. Kramer, Masahiro Murakami, Yang Ou, Barry A. Borlaug
Journal of the American College of Cardiology. 202541 CitationsOPEN ACCESS
Related on ScholarIQ
Eli Lilly (United States)
Institution
Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
Paper
Salivary diagnostics: opportunities and challenges
Paper
Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
Paper
Randomized, placebo-controlled, phase III trial of sunitinib in combination with prednisone (SU+P) versus prednisone (P) alone in men with progressive metastatic castration-resistant prostate cancer (mCRPC).
Paper
Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
Paper